Bradley R. H., Barkin R. L., Jerome J., DeYoung K., Dodge C. W. Efficacy of venlafaxine for the long term treatment of chronic pain with associated major depressive disorder. // Am J Ther. – 2003. – Vol. 10. – № 5. – P.318-323.
Breitbart W., Tremblay A., Gibson C. An open trial of olanzapine for the treatment of delirium in hospitalized cancer patients. // Psychosomatics. – 2002. – Vol.43. – № 3. – P.175-182.
British National Formulary № 31. — British medical association and Royal pharmaceutical society of Great Britain. – London, 1996.
Brown S., Inskip H., Barraclough B. Causes of the excess mortality of schizophrenia. // Br J Psychiatry. – 2000. – Vol.177. – P.212-217.
Caraceni A., Grassi L. Delirium: acute confusional states in palliative medicine. // Oxford University Press, 2004.
Claude H. A propos de la schizoϊdie et de Schizophrenie. // Ann. Med. — psychol. – 1926. – P.83-84.
Cooper I. ICD-10: Mental disorders chapter of the international classification of diseases, tenth revision. // A century of psychiatry. – London. – 1999. – P.302-306.
Crow T. J. The two-syndrome concept: original and current status. // Schizophrenia bulletin. – 1985. – Vol.11. – № 3. – P.475-485.
Cummings J. L., Street J., Masterman D., Clark W. S. Efficacy of olanzapine in the treatment of psychosis in dementia with lewy bodies. // Dement Geriatr Cogn Disord. – 2002. – Vol.13. – № 2. – P.67-73.
Curkendall S. M., Mo J., Jones J. K. et al. Increased cardiovascular disease in patients with schizophrenia. // Poster presented at the annual meeting of the American Psychiatric Association, New Orleans, LA, May 8, 2001.
Czech B, Kucewicz E, Frank M. Neuropsychiatric complication after surgical procedures – literature review. // Wiad Lek. – 2003. – Vol.56. – № 11-12. – P.556–559.
Davidson S., Judd F., Jolley D. et al. Cardiovascular risk factors for people with mental illness. // Aust N ZJ Psychiatry. – 2001. – Vol.35. – P.196-202.
Davis G. C., Buchsbaum M. S. Pain sensitivity and endorphins in functional psychoses. // Modren problems in Pharmacopsychiatry. — 1981. — Vol.17. — P.97-108.
Dawson J. H., Sussams P., Grounds A. T. at al. Assocations of Self-Reported Past «Psychotic» Phenomena With Features of Personality Disorders. // Comprehensive Psychiatry. – 2000. – Vol.41. – № 1. – P.42-48.
de Leon J., Dadvand M., Canuso C. et al. Schizophrenia and smoking: an epidemiological survey in a state hospital. // Am J Psychiatry. – 1995. – Vol.152. – P.453-455.
Diagnostic and Statistical Manual of Mental Disorders (DSM-IV) Text Revision, APA., 1994.
Dixon L., Weiden P., Delahanty J., Goldberg R., Postrado L., Lucksted A., Lehman A. Prevalence and correlates of diabetes in national schizophrenia samples. // Schizophr Bull. – 2000. – Vol.26. – № 4. – P.903-912.
Dimitrijevic D. T. The concept of schizasthenia and its clinical aspects. // Ann Med Psychol (Paris). – 1952. – Vol. 110 – № . 1:3. – P.273–299.
Doogan D. P. Toleration and safety of sertraline: experience worldwide. // Int. Clin. Psychopharmacol. – 1991. — Vol.6. – Suppl. 2. — P. 47-56.
Douglas C. J., Druss R. G. Denial of illness: a reappraisal. // Gen Hosp Psychiatry. – 1987. – Vol.9. – № 1. – P. 53–57.
Dowd N. P., Karski J. M., Cheng D. C., Gajula S., Seneviratne P., Munro J. A., Fiducia D. Fast-track cardiac anaesthesia in the elderly: effect of two different anaesthetic techniques on mental recovery. // Br J Anaesth. – 2001. – Vol.86. – № 1. – P.68-76.
Drake W. M., Gordon G. D. Heart block in a patient on propranolol and fluoxetine. // Lancet. – 1994. – 12. – Vol. 343. – № . 8894. – P.425-426.
Druss R. G., Douglas C. J. Adaptive responses to illness and disability. Healthy denial. // Gen Hosp Psychiatry. – 1988. Vol.10. – № 3. – P.163-168.
Dupré E. Pathologie de l'imagination et de l'émotivité. Paris, 1925. 501 p.
Dupre E., Camus P. Les Cenestopathies. // L'Encephale. — 1907. — № 12. — P.616-631.
Ekbom K. Der Praesenile Dermatozoenwahn. // Acta psychiat Neurol Scand. – 1938. – Vol. 13. – P. 227–259.
Eriksson J. Psychosomatic aspects of coronary artery bypass graft surgery. A prospective study of 101 male patients. // Acta Psychiatr. Scand. Suppl. – 1988. – № 340. – P.1—112.
Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults. Executive Summary of The Third Report of The National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, And Treatment of High Blood Cholesterol In Adults (Adult Treatment Panel III). // JAMA. – 2001. – Vol.285. – № 19. – P. 2486-2497.
Ey H. — Evolut. psychiat. – 1958. – № 2, – P.149—211.
Fink P. Mental illness and admissions to general hospitals. A register investigation. // Acta Psychiatr Scand. – 1990. – Vol.82. – P.458-62.
Forsman A., Ohman R. Studies on serum protein binding of haloperidol. // Curr Ther Res Clin Exp. – 1977. – Vol.21. – № .2. – P.245-255.
Fresch J. The psychotic character. Clinical psychiatric considerations. // Psychiat. Quart. – 1964. – Vol.38. – P.81-96.
Fric M, Laux G. Prolactin Levels and Symptoms of Hyperprolactinemia in Patients Treated with Amisulpride, Risperidone, Olanzapine and Quetiapine. // Psychiatr Prax. – 2003. – Vol. 30. – Suppl. 2. – P.97–101.
Frye M. A., Coudreaut M. F., Hakeman S. M., Shah B. G., Strouse T. B., Skotzko C. E. Continuous droperidol infusion for management of agitated delirium in an intensive care unit. // Psychosomatics. – 1995. – Vol.36. – № .3. – P.301-305.
Gaupp R. Uber paranoische Verenlagung und abortive Paranoia. // Allg. Zeitschrift fur Psychiatrie. — 1910. — Bd. 64. — S.317—321.
Glassman A. H., O'Connor C. M., Califf R. M., Swedberg K., Schwartz P., Bigger J. T. Jr, Krishnan K. R., van Zyl L. T., Swenson J. R., Finkel M. S., Landau C., Shapiro P. A., Pepine C. J., Mardekian J., Harrison W. M., Barton D., McIvor M. Sertraline treatment of major depression in patients with acute MI or unstable angina. // JAMA. – 2002. – Vol. 288. – № .6. –P.701-709.
Glatzel G. Autochtone Asthenien. // Z. Nеurol. u. Psychiat. – 1972. – Bd.10. – S.596 –601.
Glatzel J. On the differential diagnosis of juvenile asthenic failure syndromes. // Schweiz Arch Neurol Neurochir Psychiatr. – 1969. – Vol.104. – № .1. – P.151-162.
Gokgoz L, Gunaydin S, Sinci V, Unlu M, Boratav C, Babacan A, Soncul H, Halit V, Inanir S, Ersoz A. Psychiatric complications of cardiac surgery postoperative delirium syndrome. // Scand Cardiovasc J. – 1997. – Vol. 31. – № .4. – P.217-222.
Goldberg D., Huxley P. Common Mental Disorders. A Bio-Social Model. London: Routledge, 1992.
Goldstein J. M. The new generation of antipsychotic drugs: how atypical are they? // Int J Neuropsychopharmacol. – 2000. – Vol.3. – № .4. – P.339-349.
Guy W. Clinical Global Impressions (CGI) scale. // ECDEU Assessment Manual for Psychopharmacology — Revised (DHEW Publ No ADM 76-338). Rockville, MD, U. S. Department of Health, Education, and Welfare, Public Health Service, Alcohol, Drug Abuse, and Mental Health Administration, NIMH Psychopharmacology Research Branch, Division of Extramural Research Programs. – 1976. – P.218-222.
Haddad PM, Wieck A. Antipsychotic-induced hyperprolactinaemia: mechanisms, clinical features and management. // Drugs. – 2004. – Vol. 64. – № . 20. – P.2291-2314.
Haines J., Barclay P., Wauchob T. Optimising management of delirium. Withdrawal of Droleptan (droperidol). // BMJ. – 2001. – Vol. 322. – № .7302. – P.1603.
Harrigan E. P., Miceli J. J., Anziano R., Watsky E., Reeves K. R., Cutler N. R., Sramek J., Shiovitz T., Middle M. A randomized evaluation of the effects of six antipsychotic agents on QTc, in the absence and presence of metabolic inhibition. // J Clin Psychopharmacol. – 2004. – Vol.24. – № .1. – P.62-69.
Harter M. Etiology of mental disorders in chronic somatic illness. // Rehabilitation (Stuttg). – 2002. – Vol.41. – № .6. – P.357-366.
Heinroth // Цит.: Каннабих Ю. В. —Сов. невропатол. психиатр, и психогиг. – 1934, – т. 3. – № 5. – C. 6—13.
Herrmann N., Rivard M. F., Flynn M., Ward C., Rabheru K., Campbell B. Risperidone for the treatment of behavioral disturbances in dementia: a case series. // J Neuropsychiatry Clin Neurosci. – 1998. – Vol.10. – № .2. – P.220-223.
Hoch P., Polatin Ph. Pseudoneurotic forms of schizophrenia. // Psychiatr. Q. – 1949. – Vol. 23. – № .2. – P. 248 – 276.
Hollender M. H. Ambulatory schizophrenia. // J. Chron. Dis. – 1959. Vol.9. – P.249—259.
Huber G. Cenesthetic schizophrenia as a significant type in schizophrenic diseases. // Acta Psychiatr Scand. – 1971. – Vol.47. – № .3. – P.349-362.
Huber G. Indizen fur die Somatosehypothese bei den Schizophrenien. // Fortschr. Neurol. Psychiat. –1976. — Bd.44. — № 3. — S.77-94.
Huber G. Das Konzept substratnaher Basissymptome und seine Bedeutung für Theorie und Therapie schizophrener Erkrankungen. // Nervenarzt. – 1983. – Bd.54. – P.23-32.
Hughes J. R., Hatsukami D. K., Mitchell J. E. et al. Prevalence of smoking among psychiatric outpatients. // Am J Psychiatry. – 1986. – Vol.143. – P.993-997.
Hugues F. C., Munera Y., Jeunne C. Le Hypotensions orthostatiques medicamenteuses. // Rev. Med. Interne. – 1992. – Vol.13. – P.465-470.
Iapichino G., Bertolini G., Pezzi A., Rossi C., Melotti R., Valdambrini F., Albicini M., Di Mauro P. Use of sedative and analgesic drugs in the first week of ICU stay in high-level-of-care. // Minerva Anestesiol. – 2003. – Vol.69. – № .10. – P.765-774.
Ishihara H., Satoh Y., Kudo H., Yasuda T., Koh H., Matsuki A. No psychological emergence reactions in schizophrenic surgical patients immediately after propofol, fentanyl, and ketamine intravenous anesthesia. // J Anesth. – 1999. – Vol.13. – № .1. – P.17-22.
Isles L. J., Orrell M. W. Secondary mania after open-heart surgery. // Br J Psychiatry. – 1991. – Vol.159. – P.280-282.
Jahrreis W. Das hypochondrishe Denken //Arch. Psychiatr. Nervenkr. – 1930. – Bd.92. – S.686-823.
Jindal R., MacKenzie E. M., Baker G. B., Yeragani V. K. Cardiac risk and schizophrenia. // J Psychiatry Neurosci. – 2005. – Vol. 30. – № . 6. – P.393-395.
Jones B, Basson BR, Walker DJ, Crawford AM, Kinon BJ. Weight change and atypical antipsychotic treatment in patients with schizophrenia. // J Clin Psychiatry. – 2001. – Vol. 62. – Suppl. 2. – P.41-44.
Kahn E. Zeitschr Neurol Psychiat. – 1921. – Bd. 66. – S. 273-282.
Kaplan H. I., Sadok B. J. Synopsis of Psychiatry. // Baltimore, 1997.
Karlsson H., Joukamaa M., Lehtinen V. Differences between patients with identified and not identified psychiatric disorders in primary care. // Acta Psychiatr Scand. – 2000. – Vol.102. – № . 5. – P.354-358.
Khouzam HR, Donnelly NJ. Remission of self-mutilation in a patient with borderline personality during risperidone therapy. // J Nerv Ment Dis. – 1997. – Vol. 185. – № .5. – P.348-349.
Kim KS, Pae CU, Chae JH, Bahk WM, Jun T. An open pilot trial of olanzapine for delirium in the Korean population. // Psychiatry Clin Neurosci. – 2001. – Vol.55. – № .5. – P.515-519.
Kim KY, Bader GM, Kotlyar V, Gropper D. Treatment of delirium in older adults with quetiapine. // J. Geriatr. Psychiatry Neurol. – 2003. – Vol.16. – № .1. – P.29-31.
Kloos G. – цит. по: Снежневский А. В. В. Х. Кандинский. Биографический очерк. // В кн.: Кандинский В. Х. О псевдогаллюцинациях. М., 2003.
Kotrla KJ, Chacko RC, Barrett SA. A case of organic mania associated with open heart surgery. // J. Geriatr. Psychiatry Neurol. – 1994. – Vol.7. – № .1. – P.8-12.
Kraushar MF. Recognizing and managing the litigious patient. // Surv. Ophthalmol. – 1992. – Vol.37. – № .1. – P.:54-56.
Kretschmer E. Der sensitive Beziehungswahn, Aufl 4. Springer-Verlag, Berlin,1918
Kretschmer E. Der sensitive Beziehungswahn. Ein Beitrag zur Para-noiafrage und zur psychiatrischen Charakterlehre. Berlin, 1927.
Kretschmer E. Grundsätzliches zur modern Entwicklung der Paranoialehre. // Nervenarzt. – 1950. – Bd.21. – S.1-12.
Laederach-Hofmann K., Fisch H. U. Diagnosis and therapy of depression in the heart disease patient. // Ther Umsch. – 2003. – Vol.60. – № . 11. – P.703-707.
Langfeldt G. The prognosis in schizophrenia and the factors influencing the course of the disease. Melf, London. – 1937.
Langfeldt G. The schizophreniform states. // Munksgaard, Copenhagen. – 1939.
Laury G., Meerloo J. A. M. Adaptive Disability: Some Precipitating Factors in Schizophrenic Decompensation. // Psychiat. Quart. – 1969. — V.43. — № 2. – P.319-330.
Leso L., Schwartz T. L. Ziprasidone treatment of delirium. // Psychosomatics. – 2002. – Vol. 43. – № . 1. – P.61-62.
Lenze E. J., Shear K., Mulsant B. H., Reynolds C. F. Anxiety disorders in late life: an evolving picture. // CNS Spectr. – 2002. – Vol.7. – № .11. – P.805-810.
Levenson J. L. High-dose intravenous haloperidol for agitated delirium following lung transplantation. // Psychosomatics. – 1995. – Vol.36. – № .1. – P.66-68.
Levenson J. L. The American Psychiatric Publishing Textbook of Psychosomatic Medicine. //APP, NY, 2004
Lieberman JA 3rd. Metabolic changes associated with antipsychotic use. // Prim Care Companion J Clin Psychiatry. – 2004. – Vol.6. – Suppl. 2. – P.8-13.
Lindstrom E, Farde L, Eberhard J, Haverkamp W. QTc interval prolongation and antipsychotic drug treatments: focus on sertindole. // Int J Neuropsychopharmacol. – 2005. – Vol.8. – № .4. – P.615-629.
Lipowski Z. J. Delirium updated. // Compr Psychiatry. – 1980. – Vol.21. – № .3. – P.190-196.
Lipowski Z. J. Somatization and depression. // Psychosomatics. – 1990. – Vol. 31. – № .1. – P.13-21.
Liptzin B. What criteria should be used for the diagnosis of delirium? // Dement Geriatr Cogn Disord. – 1999. – Vol. 10. – № .5. – P.364-367.
Lyons M. J. Epidemiology of personality disorders. // In: Textbook in psychiatric epidemiology. New York. – 1995. – P.407—436.
Madhusoodanan S, Brenner R, Alcantra A. Clinical experience with quetiapine in elderly patients with psychotic disorders. // J Geriatr Psychiatry Neurol. – 2000. – Vol. 13. – № .1. – P.28-32.
Magnan V. Lecons clinique sur les maladies mentales, Paris. – 1893.
Magnan V., du Saule L. Les dégénérés. Paris. – 1895.
Marks I. M. Review of behavioral psychotherapy, I: Obsessive-compulsive disorders. // Am J Psychiatry. – 1981. – Vol.138. – № .5. – P.584-592.
Marsh L., Lyketsos C., Reich S. G. Olanzapine for the treatment of psychosis in patients with Parkinson's disease and dementia. // Psychosomatics. – 2001. – Vol. 42. – № .6. – P.477-481.
Mayer-Gross W. (1932) Die Klinik. Handbuck der Geistes Krankheitcn (Herausgegeben Von Bumke). – 1932. – 9. – S.112, 293.
McDermott S., Moran R., Platt T., Isaac T., Wood H., Dasari S. Heart disease, schizophrenia, and affective psychoses: epidemiology of risk in primary care. // Community Ment Health J. – 2005. – Vol.41. – № .6. – P.747-755.
McCreadie R. G. Diet, smoking and cardiovascular risk in people with schizophrenia: descriptive study. // Br J Psychiatry. – 2003. – Vol.183. – 534-539.
Meagher D. J. Delirium: optimising management. // BMJ. – 2001. – Vol. 322. – P.144—149.
Meehan K. M., Wang H., David S. R., Nisivoccia J. R., Jones B., Beasley C. M. Jr., Feldman P. D., Mintzer J. E., Beckett L. M., Breier A. Comparison of rapidly acting intramuscular olanzapine, lorazepam, and placebo: a double-blind, randomized study in acutely agitated patients with dementia. // Neuropsychopharmacology. – 2002. – Vol.26. – № .4. – P.494-504.
Meltzer H. Y. Cognitive factors in schizophrenia: causes, impact, and treatment. // CNS Spectr. – 2004. – Vol.9. – № .10. – Suppl. 11. – P.15-24.
Menza M. A., Murray G. B., Holmes V. F., Rafuls W. A. Controlled study of extrapyramidal reactions in the management of delirious, medically ill patients: intravenous haloperidol versus intravenous haloperidol plus benzodiazepines. // Heart Lung. – 1988. – Vol.17. – № .3. – P.238-241.
Merskey H., Shafran B. Political hazards in the diagnosis of «sluggish schizophrenia». // Brit. J. Psychiat. – 1986. – Vol. 148. – P.247-256.
Mets T. F. Drug-induced orthostatic hypotension in older patients. // Drugs Aging –1995 — Vol.6 — P.219-228.
Middlehurst R., Coulthard P. The effect of midazolam sedation on indicators for myocardial ischemia. // Oral Surg Oral Med Oral Pathol Oral Radiol Endod. – 1999. – Vol.88. – № .4. – P.400-405.
Mitsuda H. On a pedigree of atypical psychoses. // Folia Psychiat. Neurol. Jap. – 1950. – Vol. 4. – № .2. – P. 115—122.
Mohlen K., Davies-Osterkamp S. Psychic and medical reactions in patients undergoing open heart surgery in relation to preoperative psychological condition. // Z Psychosom Med Psychoanal. – 1979. – Vol. 25. – № .2. – P.128-140.
Molina V., Gispert J. D., Reig S., Pascau J., Martinez R., Sanz J., Palomo T., Desco M. Olanzapine-induced cerebral metabolic changes related to symptom improvement in schizophrenia. // Int Clin Psychopharmacol. – 2005. – Vol.20. – № .1. – P.13-18.
Moller P., Husby R. The initial prodrome in schizophrenia: naturalistic core dimensions of experience and behaviour. // Schizophrenia Bulletin. – 2000. – Vol.26. – № .1. – P.217-232.
Mundt Ch. Residual Apathiesyndrom der Schizophrenen. Ergebnisse einer psychopathologischen Langzeitstudio. //Nervenarzt. – 1938. – Bd.54. — S.131—138.
Napolitano C., Priori S. G., Schwartz P. J. Torsade de pointes. Mechanisms and management. // Drugs — 1994 — Vol.47 — P.51-65.
Neehall J., Beharry N. The pattern of in-patient psychiatric referrals in a general hospital. // West Indian Med J. – 1993. – Vol.42. – № .4. – P.155-157.
Ness D. E., Ende J. Denial in the medical interview. Recognition and management. // JAMA – 1994. – Vol. 272. — № 22. –P.1777-1781.
Nyman A. K. Non-regressive schizophrenia. Clinical course and outcome. // Acta psychiat. scand. – 1978. – Suppl. 272. – P.143.
O'Keeffe S. T., Lavan J. N. Clinical significance of delirium subtypes in older people. // Age Ageing. – 1999. – Vol.28. – № .2. – P.115-119.
Osby U., Correia N., Brandt L. et al: Mortality and causes of death in schizophrenia in Stockholm County, Sweden. // Schizophr Res. – 2000. – Vol.45. – P.21-28.
Pae C. U., Lee S. J., Lee C. U., Lee C., Paik I. H. A pilot trial of quetiapine for the treatment of patients with delirium. // Hum Psychopharmacol. – 2004. – Vol.19. – № .2. – P.125-127.
Passik S. D., Cooper M. Complicated delirium in a cancer patient successfully treated with olanzapine. // J Pain Symptom Manage. – 1999. –Vol.17. – № .3. – P.219-223.
Pick A. Zur Lehre von der initialen Erscheinung der Paranoia. // Neurol. Centralbl. — 1902. — N.1.
Pilowsky I. Dimensions of hypochondriasis. // Br J Psychiatry. –1967. – Vol.113. – № .494. – P.89-93.
Pilowsky I. Abnormal illness behaviour. // Br J Med Psychol. – 1969. – Vol.42. – № .4. – P.347-351.
Pilowsky I. A general classification of abnormal illness behaviours. // Br J Med Psychol. – 1978. – Vol. 51. – № .2. – P.131-137.
Pilowsky I., Spence N. D., Waddy J. L. Illness behaviour and coronary artery by-pass surgery. // J Psychosom Res. – 1979. – Vol.23. – № .1. – P.39-44.
Pilowsky I., Whan N. Induced distortion of body image perception. // J Psychosom Res. – 1970. – Vol.14. – № .1. – P.51-57.
Pollock B. G., Laghrissi-Thode F., Wagner W. R. Evaluation of platelet activation in depressed patients with ischemic heart disease after paroxetine or nortriptyline treatment. // J Clin Psychopharmacol. – 2000. – Vol.20. – № .2. – P.137-140.
Popper E. Z. Ges. Neurol. Psychiat. – 1920. – Vol.62. – № .3. – P.194-207.
Pourcher E., Filteau M. J., Bouchard R. H., Baruch P. Efficacy of the combination of buspirone and carbamazepine in early posttraumatic delirium. // Am J Psychiatry. – 1994. – Vol.151. – № .1. – P.150-151.
Rado S. Dynamics and classification of disordered behavior. // Am J Psychiatry. – 1953. – Vol.110. – № .6. – P.406-416.
Rao B. R., Rambhau D. Absence of a pharmacokinetic interaction between quinidine and diazepam. // Drug Metabol. Drug Interact. – 1995. — Vol.12. — P.45-51.
